These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28808039)

  • 1. Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Kates M; Date A; Yoshida T; Afzal U; Kanvinde P; Babu T; Sopko NA; Matsui H; Hahn NM; McConkey DJ; Baras A; Hanes J; Ensign L; Bivalacqua TJ
    Clin Cancer Res; 2017 Nov; 23(21):6592-6601. PubMed ID: 28808039
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
    Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
    Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
    Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
    J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
    Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
    J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
    Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
    Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethylene glycol)-Polycaprolactone Block Copolymeric Nanoparticles.
    Yen YT; Wang X; Zhang H; Wang C; Lin Z; Xie C; Liu Q; Wang L; Yu L; Li X; Lv X; Liu B; Li R
    J Biomed Nanotechnol; 2020 Mar; 16(3):335-343. PubMed ID: 32493543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell.
    Ahmad Z; Tang Z; Shah A; Lv S; Zhang D; Zhang Y; Chen X
    Macromol Biosci; 2014 Sep; 14(9):1337-45. PubMed ID: 24933015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
    Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
    J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy.
    Guo S; Miao L; Wang Y; Huang L
    J Control Release; 2014 Jan; 174():137-42. PubMed ID: 24280262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
    Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
    Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
    Chiang CS; Tseng YH; Liao BJ; Chen SY
    Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
    Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
    Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
    Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
    J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
    Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
    BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.